Showing 921-930 of 3427 results for "".
Affirming the Benefits of Full Body Skin Exams… And Overcoming Obstacles
https://practicaldermatology.com/topics/general-topics/PD0909_08-php/22772/Dermatologist-initiated full body skin exams identify skin cancers when they are most treatable. So why are some patients still not receiving exams?Understanding PML and Risks Associated with Biologic Therapies
https://practicaldermatology.com/topics/psoriasis/PD0509_10-php/22832/A swarm of controversy has enveloped biologics due to concerns about progressive multifocal leukoencephalopathy.Ethics and Dermatology: Finding Harmony in Daily Practice
https://practicaldermatology.com/topics/general-topics/PD0109_06-php/22893/While there are no easy resolutions to ethical dilemmas, experts emphasize the importance of reflection and discussion in building higher ethical standards.An Overview of Topical Therapies for Managing Pediatric AD
https://practicaldermatology.com/topics/atopic-dermatitis/an-overview-of-topical-ththerapies-for-managing-pediatric-ad/54375/Moisturization is foundational in AD management; no specific formulation has demonstrated superiority, and excessive bathing may worsen disease via increased transepidermal water loss. Topical corticosteroids and calcineurin inhibitors remain first-line due to strong efficacy data, cost-effectiveneEmerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
https://practicaldermatology.com/programs/cme/emerging-and-practice-changing-data-in-immunotherapy-strategies-for-melanoma/36330/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
https://practicaldermatology.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iibiic-melanoma/36324/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
https://practicaldermatology.com/programs/cme/clinical-data-prompting-guideline-updates-for-subcutaneous-icis-in-melanoma/36329/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma
https://practicaldermatology.com/programs/cme/clinical-implications-of-neoadjuvant-therapy-guideline-updates-in-resectable-melanoma/36323/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Tri-State Analysis of the Distribution of Southeastern Dermatologists and Dermatology Residency Graduates Among Rural and Urban Areas
https://practicaldermatology.com/issues/november-2024/tri-state-analysis-distribution-southeastern-dermatologists-and-dermatology-residency-graduates-among-rural-and-urban-areas/29799/The nation faces a shortage of dermatologists, and this issue is most prevalent in rural areas. The objective of this study is to analyze the distribution of dermatologists and graduates of dermatology residency programs across the southeastern region and the factors that influence this distributionAsk Me Anything: Mona Sadeghpour, MD
https://practicaldermatology.com/youngmd-connect/wrap-ups/ask-me-anything-mona-sadeghpour-md/24215/An intimate YoungMD Connect virtual mentorship event encourages exchange of ideas, advice, and feedback.